Global OTC Consumer Health Products Market Size, Trends, Industry Analysis, Demand, Growth Opportunity, Regional Outlook By Product Type, Distribution Channel, By Intended Audience - Industry Forecast 2017-2030

Global OTC Consumer Health Product Market Overview

Consumers are increasingly in charge of their decisions as they begin to recognize the better outcomes that come with it, they pay more out-of-pocket, and they have a number of options fueled by innovation in the industry. The battleground is gaining clarity, as payers and providers compete with one another at each consumer journey stage, from initial engagement, to education, to ongoing dialogue. Cipla Health increased the size its consumer health product portfolio by launching pipeline products in child nutrition, gastrointestinal, pain and analgesic, cough and cold, and nutritional supplements.

Goldstein Market Intelligence analyst forecast the OTC consumer health product market size is growing at a CAGR of 3.1% over the forecast years and the main driver of this growth stems from prescription (Rx) drugs switching to OTC, especially in allergy care. Global sales of consumer health products reached USD 219.2 billion globally in 2017 i.e. 3% growth from 2016.

Intended Audience

• OTC Consumer Health Product Suppliers
• OTC Consumer Health Product manufacturers
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Diagnostic centers
• Academic Medical Institutes and Universities

Global OTC Consumer Health Product Market Segmentation

By Product Type

• Nutrition
• Oral Healthcare
• Skin Health
• Vitamins & Dietary Supplements
• Herbal & Traditional Products
• Wound Care
• Digestive Remedies
• Sleep Aids
• Emergency Contraception
• Cough Cold & Allergy Remedies
• Analgesics
• Dermatological
• Eye Care
• Smoking Cessation Aids

By Distribution Channel

• Online Stores
• Offline Stores
  • Departmental Stores
  • Pharmacy Stores
• Others

Based on Geography

• North America (U.S. & Canada) OTC Consumer Health Product Market {Market Share (%), Market Size (USD Billion)}
• Latin America (Brazil, Mexico, Argentina & Rest of Latin America) OTC Consumer Health Product Market {Market Share (%), Market Size (USD Billion)}
• Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) OTC Consumer Health Product Market {Market Share (%), Market Size (USD Billion)}
• Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) OTC Consumer Health Product Market {Market Share (%), Market Size (USD Billion)}
• Middle East & Africa (GCC, South Africa, North Africa, RoMEA) OTC Consumer Health Product Market {Market Share (%), Market Size (USD Billion)}

Based on product type, cough cold & allergy remedies segment lead the OTC consumer health products and accounted for the market share of 33.3% in 2017 due to growing awareness regarding lifestyle diseases, increase in self-medication and increase in switch from prescription to OTC products. Herbal & traditional products are the second largest OTC consumer health product market followed by sleep aids and emergency contraception. Nutrition, oral healthcare and digestive remedies are the fastest growing segments owing to widespread outreach of social media, accelerated use of online resources, new product launches, aggressive market and promotion activities, and strategic alliances.

Global OTC Consumer Health Product Market Trends, Share, & Challenges Analysis

Global OTC Consumer Health Product Market Outlook 2017-2030, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the global OTC Consumer Health Product Market. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. Global OTC Consumer Health Product Market report also recognizes value chain analysis to understand the cost differentiation to provide competitive advantage to the existing and new entry players.

According to our global market study on the basis of extensive primary and secondary research: “One trend is the push to switch drugs from prescription to OTC or non-prescription drugs which continues to bring new market expansion opportunities for firms, which is valid in the therapeutic areas of respiratory and digestive health and esomeprazole.”

According to the report, major driving factor is the personalization of consumer health that leads to formidable shift toward lifestyle and wellness programs supported by a holistic approach to self-care. More than 60% of consumers are now always on and readily addressable yet the healthcare industry is just starting to use mobile and social channels as effective engagement channels. In 2015, 32% of American used a mobile app for medical, health, or fitness information, and when people move to mobile they expect real-time reactions.   

Further, the report states the biggest challenge is the adverse effects of supplements taken without any physician’s guidance can send the person to the emergency department. According to The New England Journal of Medicine, adverse effects of supplements were responsible for an average of about 23,000 emergency department (ED) visits per year and over 10% of these visits resulted in admission to the hospital, especially among adults older than 65. Weight-loss products accounted for one quarter of all single-product ED visits and disproportionately affected women, while men were more likely to experience adverse effects from products advertised for sexual enhancement and body building. Energy-boosting products made up another 10% of these visits.

Based on geography, North America held the largest OTC consumer health products and U.S. continues to dominate the OTC consumer health products market representing 30% of the overall industry at USD 38.9 billion in 2017. US Coupled with China, Japan, Germany and Italy comprises of 61% of global sales within consumer health, confirming that the industry is mainly driven by developments in a few geographies. While South Korea, France, India and Mexico amongst others signals an opportunity for market expansion with only 3-4% global share in 2017.

Covered In This Global OTC Consumer Health Product Market Report  

The report covers the present ground scenario and the future growth prospects of the OTC Consumer Health Product market for 2017-2030 along with the data of end user medical facilities worldwide. We calculated the market size and revenue share on the basis of revenue generated from major players across the globe. The OTC Consumer Health Product Market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players. The report also includes micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

 The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Market Players 

Our global OTC Consumer Health Product Market report comprises of the following companies as the key players:

• Sun Pharmaceuticals Ltd.
• Abbott Laboratories
• GlaxosmithKline plc
•  Pfizer Inc.
•  Johnson & Johnson
•  Piramal Enterprises Ltd.
•  Ipsen
•  Sanofi S.A.
•  Bayer AG
•  American Health
•  Boehringer Ingelheim
•  Novartis
•  PGT healthcare
•  Takeda and Glenmark Pharmaceuticals Ltd.

For a full detailed overview, send us the sample request.

Key questions answered in this OTC Consumer Health Product Market Report

• What is the total market size by 2030 and what would be the expected growth rate of market?
• What is the revenue of total market in 2016-17 and what would be the expected demand over the forecast period?
• What are the key market trends?
• What are the factors which are driving this market?
• What are the major barriers to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities for the existing and entry level players?
• What are the recent developments and business strategy of the key players?

We can provide two hour complimentary interaction with our analyst after the purchase of this market report. Details are imparted within the report.